12 octubre 2016

Yondelis Iniciara en Breve una Nueva Fase III en Holanda de la Mano de la EORTC .

Mas Espectativas ...

Trabectedin Maintenance Post 1st-line in STS .

This study is not yet open for participant recruitment.

Verified October 2016 by European Organisation for Research and Treatment of Cancer - EORTC .

Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC .

Collaborator:
PharmaMar .

Information provided by (Responsible Party):

European Organisation for Research and Treatment of Cancer - EORTC

Maintenance therapy with trabectedin versus observation after first line treatment with doxorubicin of patients with advanced or metastatic soft tissue sarcoma.

This is a prospective, multicenter, randomized, open label Phase III trial investigating whether a maintenance treatment with trabectedin, as compared to the observational approach, can prolong progression-free survival in patients with advanced, inoperable and/or metastatic STS after response or stabilisation during first line treatment with doxorubicin.



Locations :
Netherlands
Leiden University Medical Center Not yet recruiting
Leiden, Netherlands